Stroke thrombolysis has definitely put the spotlight back on to the topic of stroke care over the last few years.

Thrombolysis led to restructuring of stroke care in the UK and has helped drive investment in stroke care. The evidence base that underpins thrombolysis has been controversial to say the least and can be difficult to comprehend.

The article, published in the the Emergency Medicine Australasia Journal is a great place to start to get to grips with the topic.

In the podcast we run through the paper and hopefully this will shed act as a good recap on the topic and lead you to delve into the primary literature and form your own opinion.

Enjoy!

References

Review article: Why is there still a debate regarding the safety and efficacy of intravenous thrombolysis in the management of presumed acute ischaemic stroke? A systematic review and meta-analysis. Donaldson L. Emerg Med Australas. 2016 Aug 25

Royal College of Physicians; National clinical guideline for stroke, Prepared by the Intercollegiate Stroke Working Party, Fifth Edition 2016 (accredited by NICE)

NICE; Acute Stroke Pathways

NICE; Patient Information for Stroke Thrombolysis

The review of alteplase in the treatment of acute ischaemic stroke by the expert working group of the Commission on Human Medicines

Review of Altepase Licensing; BMJ Online

Alteplase licensing